NO20045304L - Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme - Google Patents

Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Info

Publication number
NO20045304L
NO20045304L NO20045304A NO20045304A NO20045304L NO 20045304 L NO20045304 L NO 20045304L NO 20045304 A NO20045304 A NO 20045304A NO 20045304 A NO20045304 A NO 20045304A NO 20045304 L NO20045304 L NO 20045304L
Authority
NO
Norway
Prior art keywords
substance
administration
fsh
amount equivalent
unit containing
Prior art date
Application number
NO20045304A
Other languages
English (en)
Norwegian (no)
Inventor
Herman Jan Tijmen Coel Bennink
Evert Johannes Bunschoten
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20045304L publication Critical patent/NO20045304L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20045304A 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme NO20045304L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077221 2002-06-07
PCT/NL2003/000370 WO2003103770A2 (en) 2002-06-07 2003-06-06 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Publications (1)

Publication Number Publication Date
NO20045304L true NO20045304L (no) 2005-02-07

Family

ID=29724462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045304A NO20045304L (no) 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Country Status (21)

Country Link
US (1) US7815912B2 (sr)
EP (1) EP1511537B1 (sr)
JP (1) JP2005530818A (sr)
KR (1) KR20050058285A (sr)
CN (1) CN1684737A (sr)
AU (1) AU2003274929B2 (sr)
BR (1) BR0305033A (sr)
CA (1) CA2488719A1 (sr)
EA (1) EA009371B1 (sr)
ES (1) ES2399962T3 (sr)
IL (1) IL165522A0 (sr)
IS (1) IS7586A (sr)
ME (1) MEP39308A (sr)
MX (1) MXPA04012246A (sr)
NO (1) NO20045304L (sr)
NZ (1) NZ536984A (sr)
PL (1) PL373991A1 (sr)
RS (1) RS105004A (sr)
UA (1) UA81251C2 (sr)
WO (1) WO2003103770A2 (sr)
ZA (1) ZA200409857B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473746T1 (de) * 2007-01-08 2010-07-15 Pantarhei Bioscience Bv Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
BR112014001274A2 (pt) 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
UA127283C2 (uk) 2016-07-21 2023-07-12 Обсева С.А. Спосіб застосування антагоніста окситоцину для сприяння імплантації ембріона і запобігання викидню
US20220323410A1 (en) 2019-09-03 2022-10-13 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2021160597A1 (en) 2020-02-10 2021-08-19 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
WO2026018221A1 (en) 2024-07-18 2026-01-22 ReproNovo SA Crystalline compositions for improving embryo implantation and methods of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
CN1199642A (zh) * 1997-05-16 1998-11-25 Asta药物股份公司 治疗不育症的lhrh－拮抗剂
ATE302018T1 (de) 1997-06-20 2005-09-15 Akzo Nobel Nv Gonadotropin releasing hormon antagonist
CZ301912B6 (cs) * 1998-04-23 2010-07-28 Zentaris Ivf Gmbh Lécivo na lécení neplodnosti nitrodeložní inseminací
CN1353617A (zh) * 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
WO2001000227A1 (en) * 1999-06-23 2001-01-04 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
DE60231892D1 (de) * 2001-09-12 2009-05-20 Serono Lab Verwendung von lh für die kontrollierte ovarielle hyperstimulation
AU2002358346A1 (en) 2001-12-21 2003-07-15 Pantarhei Bioscience B.V. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Also Published As

Publication number Publication date
CN1684737A (zh) 2005-10-19
NZ536984A (en) 2008-01-31
US7815912B2 (en) 2010-10-19
MEP39308A (en) 2011-02-10
EA200401619A1 (ru) 2005-06-30
UA81251C2 (en) 2007-12-25
BR0305033A (pt) 2004-11-09
IS7586A (is) 2004-12-03
EP1511537A2 (en) 2005-03-09
RS105004A (sr) 2007-02-05
WO2003103770A3 (en) 2004-04-22
ZA200409857B (en) 2006-02-22
ES2399962T3 (es) 2013-04-04
PL373991A1 (en) 2005-09-19
MXPA04012246A (es) 2005-04-08
KR20050058285A (ko) 2005-06-16
CA2488719A1 (en) 2003-12-18
US20050235374A1 (en) 2005-10-20
IL165522A0 (en) 2006-01-15
EA009371B1 (ru) 2007-12-28
AU2003274929A1 (en) 2003-12-22
WO2003103770A2 (en) 2003-12-18
AU2003274929B2 (en) 2008-04-10
EP1511537B1 (en) 2012-11-21
JP2005530818A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
Schally et al. LH‐RH agonists and antagonists
Ayalon et al. Acute Effect of▵ 1–Tetrahydrocannabinol on the Hypothalamo-Pituitary-Ovarian Axis in the Rat
Lin et al. Effects of [d-Arg6, Trp7, Leu8, Pro9 NEt]-luteinizing hormone-releasing hormone (sGnRH-A) and [d-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide or domperidone, on Gonadotropin release and ovulation in the Chinese loach and common carp
ITMI941048A1 (it) Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
AU2002310788B2 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
Sahu et al. Dynamic changes in neuropeptide Y concentrations in the median eminence in association with preovulatory luteinizing hormone release in the rat
NO20045304L (no) Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
EA001178B1 (ru) Применение lhrh-аналога или комбинации lhrh-аналогов и антиэстрогена с селективным по отношению к тканям эстрогенным действием для лечения гинекологических нарушений
Corbin et al. Peptide Contraception: Antifertility Properties of LH‐RH Analogues
Neidhart Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion
Volkmann et al. Failure of hCG to support luteal function in bitches after estrus induction using deslorelin implants
RU2181598C2 (ru) Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
PT1425033E (pt) Utilização de hcg e lh na hiper-estimulação controlada dos ovários
US20210137923A1 (en) Treatment of sexual dysfunction
Grossman Opioid peptides and reproductive function
CA2472309A1 (en) Multiple dose aromatase inhibitor for treating infertility
Kasting et al. Endogenous prostaglandins affect growth hormone and thyrotropin release at a hypothalamic, not a pituitary level
MXPA03009447A (es) Inhibidor de aromatasa de dosis unica para tratamiento de infertilidad.
KR20030051828A (ko) 에스트로겐 의존성 질환의 병용 치료법
Omi et al. Evidence that systemic relaxin promotes moderate water consumption during late pregnancy in rats
JP2004529924A5 (sr)
van Wimersma Greidanus et al. to the Role of Opioid Peptides¹
Ayalon et al. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat
Berger et al. High dose Follicle Stimulating Hormone (FSH) and Human Menopausal Gonadotropin (HMG) combined with a single dose of Cetrorelix: can it normalize the response of the poor responder?

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application